QS Investors, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$160,000
+162.3%
4,5100.0%0.00%
+100.0%
Q1 2020$61,000
-33.7%
4,5100.0%0.00%0.0%
Q4 2019$92,000
+53.3%
4,5100.0%0.00%0.0%
Q3 2019$60,000
-4.8%
4,5100.0%0.00%0.0%
Q2 2019$63,000
-27.6%
4,5100.0%0.00%0.0%
Q1 2019$87,000
+33.8%
4,5100.0%0.00%0.0%
Q4 2018$65,000
-30.9%
4,5100.0%0.00%0.0%
Q3 2018$94,000
-12.1%
4,5100.0%0.00%0.0%
Q2 2018$107,0004,5100.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders